Curcumin – Clinical Support for Bioavailability of Wacker Product

3f1475f4-f825-4f0f-b90e-05123a2ec7daarticleimage.jpg

24 Feb 2017 --- A clinical study that was recently published in the European Journal of Nutrition shows that the bioavailability of curcumin can be increased significantly with the help of gammadextrin – by a factor of 40 compared to conventional curcumin extract.

Curcumin is a powerful antioxidant that exhibits anti-inflammatory, antibacterial and hypoallergenic properties, but is not readily absorbed in the human bloodstream. CAVACURMIN, a powder-form gammadextrin-curcumin formulation, can be easily processed in food supplements, such as tablets, capsules and energy bars or functional beverages. 

“Another aspect that is very interesting for consumers is the fact that curcumin is a classical antioxidant, which means its main mode of action is via free-radical scavenging. Some studies even imply that curcumin not only neutralize free radicals, but also boosts the activity of the body’s own antioxidant enzymes, and thus helps to protects our cells from oxidative stress and damage,” she notes.

Curcumin, the active compound in turmeric has been shown to exhibit anti-inflammatory, antibacterial and hypoallergenic properties. However, because it is not water-soluble, it is not readily absorbed in the human bloodstream. With the aid of gammadextrin, curcumin’s bioavailability can be increased significantly – an effect that has now been scientifically proven once more. An independent double-blind crossover clinical study performed in the USA compared the relative absorption of CAVACURMIN (gammadextrin-curcumin formulation) with pure curcumin extract (95%) and two commercially available curcumin preparations designed to increase bioavailability. After oral ingestion of the substance, the blood of the study participants was analyzed at regular intervals over the course of 12 hours.

It was shown that CAVACURMIN was absorbed approximately 40 times more efficiently than the standard extract, and at least 4.6 times better than the next best comparable commercial product.  

The cyclic oligosaccharide gammadextrin increases the bioavailability of curcumin due to its unique properties. Gammadextrin is hydrophilic on the outside with a hydrophobic cavity on the inside, which allows it to accommodate other hydrophobic substances. In this way, cyclodextrins can bind ingredients, release active agents or stabilize sensitive substances and interfaces.  

To increase bioavailability, the water-soluble gammadextrin can encapsulate fat-soluble curcumin, for example. Hydrophobic curcumin thus gets a hydrophilic shell and therefore forms a molecular dispersion in water that leads to a much better absorption by the human body.  

As a free-flowing, dispersible powder, CAVACURMIN is suitable not only for dry or powdered food supplements, such as tablets, capsules and energy bars, but also for functional beverages. The alternative that cyclodextrins offer for many food-supplement formulations is not only cholesterol-free and non-allergenic, but also plant-based. Produced enzymatically from starch, cyclodextrins are manufactured by WACKER entirely from renewable raw materials. 

“We are very pleased with the positive results of the clinical study on the enhanced bioavailability of curcumin by gammadextrin,” said Helmut Reuscher, sales and technology director for Nutrition at WACKER BIOSOLUTIONS. “According to our customers, high bioavailability is getting more and more important in food supplements. We are very proud that our innovative cyclodextrin platform is finding more widespread use and allows our customers to make a contribution to the development of enhanced food supplements.”   

Rachela Mohr (pictured), Business Development Nutrition, WACKER BIOSOLUTIONS spoke with NutritionInsight: “At WACKER, we Click to Enlargehave been working with cyclodextrins for many years now so we surely know the properties and possibilities of these molecules very well. When we’ve developed this particular gammadextrin-curcumin complex CAVACURMIN a few years ago, we could see with our own lab tests that the bioavailability of curcumin can be increased significantly. We had some positive expectations when this clinical study started so we were very excited to see that the results were so positive for our product, especially in comparison to other market products.” 

“Generally speaking, curcumin is a quite powerful antioxidant that is supposed to have many positive properties, such as anti-inflammatory, hypoallergenic and antibacterial effects,” she explains. “Personally, I have the impression that the anti-inflammatory properties are most interesting for consumers. Inflammation processes, especially chronic inflammation, are a critical factor with many different diseases. For this reason, curcumin is already used successfully to treat joint pains due to rheumatism and arthrosis, or for gastrointestinal symptoms,” Mohr adds. 

Mohr finalizes: “In addition to the bioavailability, further studies may examine the antioxidative and anti-inflammatory properties, as these effects are of particular interest for the consumers and the dietary supplements market.”

by Elizabeth Kenward

To contact our editorial team please email us at editorial@cnsmedia.com

Wacker Chemie AG

Collapse

Wacker Biosolutions, Wacker’s life science and biotechnology division, offers a broad range of innovative tailored products and solutions for the life science sector –, particularly for the functional food and nutraceutical industries. 

These include Cavamax® W6 alpha-cyclodextrin, a natural, starch-derived oligosaccharide. It can be added as a fully fermentable dietary fiber to foods and beverages, including carbonated and non-carbonated transparent soft drinks. Cavamax® W6 is scientifically proven to significantly reduce the post-prandial glycaemic response – an effect officially acknowledged by EFSA. Besides, it interacts with triglycerides building up a surfactant-like structure that stabilizes oil-in-water emulsions efficiently. With Cavamax® W6, Wacker thus offers manufacturers a possibility to replace emulsifiers with a soluble fiber.

Furthermore, Wacker offers molecular encapsulation solutions based on our cyclodextrin technology for odor or taste-masking, to stabilize food ingredients against heat and oxidation and to increase the bioavailability of functional ingredients. We have over 15 years of experience in manufacturing and formulating alpha-, beta- and gamma-cyclodextrins. 

Additionally, Wacker produces a high-quality range of non-human, non-animal derived L-cysteine products. Wacker is the world’s only manufacturer of vegetarian-grade cysteine using a patented biotech process.

Related Articles

Health & Nutrition News

UK women of childbearing age falling short on key micronutrient requirements, survey finds

13 Aug 2018 --- The micronutrient intake of women in their childbearing years, as well as young people in general, fall short in key micronutrients such as magnesium and selenium. UK researchers note that improvements in dietary quality are needed in young adulthood and mid-life. Alongside this, fortification and supplementation strategies may be considered to help adults achieve dietary targets at this life-stage when they should be at their “nutritional prime.”

Health & Nutrition News

Montmorency tart cherries may help enhance gut health, finds small scale study

07 Aug 2018 --- Montmorency tart cherries may play a role in improving gut health, suggests a first-of-its-kind human trial of nine adults combined with a parallel laboratory study published in the Journal of Nutritional Biochemistry. An international team of scientists found that Montmorency tart cherries helped to positively impact the gut microbiome – a collection of trillions of bacteria and other microbes that live in the intestinal tract. The study has been highlighted by the trade association The Cherry Marketing Institute.

Health & Nutrition News

Premixes: Strong potential for plant-based nutritionals and protein innovation

07 Aug 2018 --- The aging of the population, increasing scientific evidence of the benefits of nutritional supplementation and the trend toward foods and beverages rather than pills and capsules have led to increased consumer interest in the incorporation of nutrient premixes to support a healthy diet. “Consumers are doing everything they can to stay healthy so that they can stay out of the traditional healthcare system,” says Sam Wright IV, CEO at The Wright Group, which develops custom nutrient premixes, the enrichment of rice and grains, as well as the microencapsulation of vitamins, minerals and omega 3.

Regulatory News

EFSA greenlights novel foods status for Biova’s egg membrane hydrolysate, amid joint health surge

06 Aug 2018 --- The European Food Safety Authority (EFSA) Panel on Dietetic Products, Nutrition and Allergies (NDA) has recognized egg membrane hydrolysate BiovaFlex as novel food pursuant to Regulation (EU) 2015/2283. According to the applicant, Biova LLC (the supplier of BiovaFlex), the ingredient holds particular market potential due to its natural sourcing credentials as well as the convenience it brings by being water-soluble.

Health & Nutrition News

Weekly Roundup: Curcumin extract may prevent non-alcoholic fatty liver disease, eggs recommended in early weaning

03 Aug 2018 --- The weekly roundup is NutritionInsight's collection of global nutrition stories from the past week. In research news, bioactive curcumin extract BCM-95 was noted for its role in preventing and treating Non-Alcoholic Fatty Liver Disease (NAFLD), folic acid supplementation may be key to lowering the risk of language skill delays in children whose mothers take drugs for epilepsy and women appear to have a more considerable aversion to eating meat than men after seeing pictures of baby animals. Lastly, British Lion Eggs, a UK food safety scheme, notes that a UK government report has highlighted the benefits of feeding the allergenic foods of eggs and peanuts to babies from the age of six months old.

More Articles
URL : http://www.nutritioninsight.com:80/news/curcumin-clinical-support-for-bioavailability-of-wacker-product.html